Vitafol-Ob+DHA (Prenatal Vit 10/Iron/Folic/DHA) Patent Expiration, LOE Window & CMS Spending

Vitafol-Ob+DHA (Prenatal Vit 10/Iron/Folic/DHA) by Exeltis USA, In: Off-Patent Genericized (AB Competition), 0 AB generics, $1.5M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorExeltis USA, In
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$1.5M
2024 Medicare Part D Spend$5K
2024 Medicaid Spend$1.5M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel